Verition Fund Management LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 46 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Verition Fund Management LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$15,641,006
-10.1%
18,003
-10.0%
0.18%
-21.6%
Q2 2023$17,403,158
+4.0%
20,003
+3.9%
0.23%0.0%
Q1 2023$16,741,171
-32.4%
19,254
-99.9%
0.23%
-40.1%
Q4 2022$24,768,955
+4.2%
27,771,000
-47.1%
0.39%
+43.9%
Q3 2022$23,772,749
+89.4%
52,542,000
+362258.6%
0.27%
+8.5%
Q2 2022$12,550,000
-66.8%
14,500
-100.0%
0.25%
-45.4%
Q1 2022$37,762,000
+22.7%
41,383,000
+23.6%
0.45%
+104.5%
Q4 2021$30,766,00033,485,0000.22%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 60,500,000$55,131,0003.79%
Ayrton Capital LLC 1,500,000$1,367,0001.78%
DeepCurrents Investment Group LLC 58,391,000$53,156,0001.66%
ABSOLUTE INVESTMENT ADVISERS, LLC 6,000,000$5,460,0001.22%
Context Capital Management, LLC 12,900$11,757,0000.76%
WOLVERINE ASSET MANAGEMENT LLC 74,842,000$68,091,0000.66%
Verition Fund Management LLC 41,383,000$37,762,0000.45%
CSS LLC/IL 13,560,000$12,426,0000.45%
Aequim Alternative Investments LP 18,000,000$16,425,0000.43%
Empyrean Capital Partners, LP 10,000,000$9,125,0000.20%
View complete list of NOVOCURE LTD shareholders